Potential Drug-Drug Interaction (PDDI) Clinical Decision Support, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nepafenac-exclude | Version: 1.0.0 | ||||
| Standards status: Informative | Computable Name: Valueset_nepafenac_exclude | ||||
Copyright/Legal: (copyright expectations unknown) |
|||||
ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://www.nlm.nih.gov/research/umls/rxnorm version Not Stated (use latest from terminology server)| Code | Display |
| 603978 | nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac] |
| 1365866 | nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro] |
| 603977 | nepafenac Ophthalmic Suspension [Nevanac] |
| 1365864 | nepafenac Ophthalmic Suspension [Ilevro] |
| 578044 | nepafenac 1 MG/ML Ophthalmic Suspension |
| 1362132 | nepafenac 3 MG/ML Ophthalmic Suspension |
| 578043 | nepafenac Ophthalmic Suspension |
| 1158407 | nepafenac Ophthalmic Product |
| 1365865 | Ilevro Ophthalmic Product |
| 1182860 | Nevanac Ophthalmic Product |
Expansion from tx.fhir.org based on codesystem RxNorm v03022026 (CodeSystem)
This value set contains 10 concepts